Difference between revisions of "Advanced Tissue Sciences"
Jump to navigation
Jump to search
m (adjust REF... parameters) |
m (add interlanguage link) |
||
| Line 1: | Line 1: | ||
<!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | <!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> | ||
'''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | '''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | ||
| − | | quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | + | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=Advanced Biohealing, Inc. | + | |publisher=Advanced Biohealing, Inc. |
| − | | | + | |date= |
| − | | title=Dermagraft-TC: Overview | + | |title=Dermagraft-TC: Overview |
| − | | url=http://www.dermagraft.com/about/overview/ | + | |url=http://www.dermagraft.com/about/overview/ |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
}}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{ REFweb | }}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{ REFweb | ||
| − | | quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin... | + | |quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin... |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=Acroposthion.com | + | |publisher=Acroposthion.com |
| − | | | + | |date= |
| − | | title=The Foreskin Mafia | + | |title=The Foreskin Mafia |
| − | | url=http://www.acroposthion.com/acroposthion_019.htm | + | |url=http://www.acroposthion.com/acroposthion_019.htm |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
}}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb | }}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb | ||
| − | | quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences. | + | |quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences. |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=SkinMedica | + | |publisher=SkinMedica |
| − | | | + | |date=2002-02-12 |
| − | | title=SkinMedica Introduces TNS Recovery Complex | + | |title=SkinMedica Introduces TNS Recovery Complex |
| − | | url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex | + | |url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
}}</ref> | }}</ref> | ||
| Line 32: | Line 32: | ||
Dermagraft-TC is FDA approved,<ref>{{REFweb | Dermagraft-TC is FDA approved,<ref>{{REFweb | ||
| − | | quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | + | |quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=MediLexicon International Ltd | + | |publisher=MediLexicon International Ltd |
| − | | date=2011 | + | |date=2011 |
| − | | title=Dermagraft-TC: General Information: Advanced Tissue Sciences | + | |title=Dermagraft-TC: General Information: Advanced Tissue Sciences |
| − | | url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | + | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation |
| − | | accessdate=2011-05-07 | + | |accessdate=2011-05-07 |
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
| − | | quote=the Food and Drug Administration has approved Dermagraft-TC | + | |quote=the Food and Drug Administration has approved Dermagraft-TC |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=HighBeam Research | + | |publisher=HighBeam Research |
| − | | date=1997-03-28 | + | |date=1997-03-28 |
| − | | title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | + | |title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA |
| − | | url=http://www.highbeam.com/doc/1G1-47248437.html | + | |url=http://www.highbeam.com/doc/1G1-47248437.html |
| − | | accessdate=2011-05-07 | + | |accessdate=2011-05-07 |
}}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> | }}</ref> and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>Circumcision. Daecher M. Icon 1998;2(2):70-3.</ref> | ||
| Line 75: | Line 75: | ||
[[Category:Financial gain]] | [[Category:Financial gain]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[de:{{FULLPAGENAME}}]] | ||
Revision as of 19:18, 17 November 2019
Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision.[1] They are also the makers of NouriCel, another product made from harvested foreskins,[2] and one of the main ingredients of SkinMedica's TNS Recovery Complex product.[3]
Earnings
Dermagraft-TC is FDA approved,[4][5] and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.[6]
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.[7]
In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.[8]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
The Foreskin Mafia
, Acroposthion.com. Retrieved 6 March 2011.
Quote:TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
- ↑ (12 February 2002).
SkinMedica Introduces TNS Recovery Complex
, SkinMedica. Retrieved 6 March 2011.
Quote:TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
- ↑ (2011).
Dermagraft-TC: General Information: Advanced Tissue Sciences
, MediLexicon International Ltd. Retrieved 7 May 2011.
Quote:Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑ (28 March 1997).
Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
, HighBeam Research. Retrieved 7 May 2011.
Quote:the Food and Drug Administration has approved Dermagraft-TC
- ↑ Circumcision. Daecher M. Icon 1998;2(2):70-3.
- ↑
Pitta, Julie: Biosynthetics. Forbes. Pp. 170-171.
Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin." - ↑ Biotech's Big Discovery. Hall CT. San Francisco Chronicle. October 25, 1996: E1, E4.
